Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

3187

Actual shortage: 257 (8%)
Anticipated shortage: 1 (0%)
Avoided shortage: 10 (0%)
Resolved: 2919 (92%)

Discontinuation Reports

435

To be discontinued: 2 (0%)
Discontinued: 410 (94%)
Reversed: 23 (5%)

Late reports

482 (13%)

Overdue reports

12 (5%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-05-20 2021-06-03 139725
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-06-03 2021-06-10 140363
TEVA-BUPRENORPHINE/NALOXONE 0.5MG 2MG TABLET Resolved 2021-08-27 2021-09-16 144704
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2022-08-18 2022-12-02 167203
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Resolved 2022-12-01 2022-12-22 176824
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2024-03-07 2024-06-27 221534
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Resolved 2024-03-07 2024-06-27 221537
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Actual shortage 2025-08-29 2025-10-30 266196
TEVA-BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Actual shortage 2025-08-29 2025-10-30 266199
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-09 2020-08-27 119889
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-16 2021-09-30 120473
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-04-29 133770
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-05-27 133776
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-06-10 2021-09-30 140675
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-27 2022-11-12 153709
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-02-17 2022-03-24 155137
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-10 2022-03-24 156407
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160427
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160432
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-27 2023-06-09 190728

Showing 921 to 940 of 3187

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.5G 4G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210194
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 4G 0.5G POWDER FOR SOLUTION Discontinued 2025-05-28 2025-05-28 258717
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-12 2018-10-12 63943
RATIO-FENOFIBRATE MC 200MG CAPSULE Discontinued 2018-10-19 2018-10-19 64891
TEVA-LENOLTEC NO. 1 300MG 8MG 15MG TABLET Discontinued 2019-04-11 2019-04-11 81362
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598
RATIO-METFORMIN 850MG TABLET Discontinued 2020-07-10 2020-07-10 120012
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2019-10-25 2019-10-26 97243
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2019-10-25 2019-10-26 97261
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2020-02-13 2020-02-13 106148
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
RATIO-TAMSULOSIN 0.4MG CAPSULE (SUSTAINED-RELEASE) Discontinued 2018-10-19 2018-10-19 64917
RATIO-TOPISALIC 20MG 0.5MG LOTION Discontinued 2024-06-28 2024-06-29 231583

Showing 121 to 140 of 435